Jianping Weng to Pandemics
This is a "connection" page, showing publications Jianping Weng has written about Pandemics.
Connection Strength
0.089
-
COVID-19 and Kawasaki disease in children. Pharmacol Res. 2020 09; 159:104951.
Score: 0.030
-
Diabetes: Leveraging the Tipping Point of the Diabetes Pandemic. Diabetes. 2017 06; 66(6):1461-1463.
Score: 0.024
-
Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study. J Diabetes Investig. 2021 Sep; 12(9):1708-1717.
Score: 0.008
-
Targeting inflammation and cytokine storm in COVID-19. Pharmacol Res. 2020 09; 159:105051.
Score: 0.007
-
A confirmed asymptomatic carrier of 2019 novel coronavirus. Chin Med J (Engl). 2020 May 05; 133(9):1123-1125.
Score: 0.007
-
Association between population migration and epidemic control of Coronavirus disease 2019. Sci China Life Sci. 2020 Jun; 63(6):936-939.
Score: 0.007
-
A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection. EBioMedicine. 2020 Nov; 61:103036.
Score: 0.002
-
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat Commun. 2020 08 06; 11(1):3924.
Score: 0.002
-
Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun. 2020 06 30; 527(3):618-623.
Score: 0.002